HIV treatment

Individual
results may vary.

How STRIBILD Can Help If You’re Starting Treatment

If you are starting treatment for HIV-1, STRIBILD® can help strengthen your immune system by lowering the amount of HIV-1 in your blood (also called viral load). By lowering your viral load, STRIBILD can also help raise the number of infection-fighting CD4 T cells in your blood.

STRIBILD was studied in 2 separate trials (called Study 103 and Study 102). To see an overview of the studies, click here. In these 2 studies, STRIBILD helped patients new to treatment reach and maintain undetectable viral loads. The results of these studies are shown below.

In one study (Study 103),

nearly 8 out of 10 patients achieved an
undetectable viral load with STRIBILD

An undetectable viral load means having less than 50 copies
per milliliter of the virus in your blood

  • In Study 103, the other medicines used were atazanavir, ritonavir, and the combination of emtricitabine and tenofovir disoproxil fumarate
  • STRIBILD worked equally as well as the other proven HIV-1 medicines

Undetectable viral load results at 3 years of treatment

353 people took STRIBILD and 78% were undetectable vs 355 people who took another HIV-1 medicine and 75% were undetectable

STRIBILD also helped increase CD4 T-cell count, which is the number of CD4 T cells per cubic millimeter of blood. Patients taking STRIBILD had an increase in their CD4 T-cell count (261 cells), which was similar to the other medicine (269 cells).

​STRIBILD does not cure HIV-1 infection or AIDS

HIV-1 is the virus that causes AIDS. There is no known cure for HIV-1 or AIDS. You must continue to take STRIBILD every day to control your HIV-1 infection and decrease illnesses caused by HIV-1 infection.

In the other study (Study 102),

STRIBILD was proven to help control HIV-1

  • In Study 102, the other medicines were a combination of efavirenz, emtricitabine, and tenofovir disoproxil fumarate
  • STRIBILD worked equally as well as the other proven HIV-1 medicine

Undetectable viral load results at 3 years of treatment

348 people took STRIBILD and 80% were undetectable vs 352 people who took another HIV-1 medicine and 75% were undetectable

In Study 102, patients taking STRIBILD had an increase in their CD4 T-cell count (298 cells), which was similar to the other medicine (272 cells).

Avoid doing things that can spread HIV-1 to other people

  • Do not share items that can have blood or body fluids on them, like needles, other injection equipment, razor blades, or toothbrushes
  • Always practice safer sex. Use protection, like latex or polyurethane condoms, when having any sexual contact

Ask your healthcare provider if you have any questions about how to prevent passing HIV-1 to other people.




IMPORTANT SAFETY INFORMATION

What is the most important information I should know about STRIBILD®?

STRIBILD can cause serious side effects:

  • Build-up of an acid in your blood (lactic acidosis), which is a serious medical emergency. Symptoms of lactic acidosis include feeling very weak or tired, unusual (not normal) muscle pain, trouble breathing, stomach pain with nausea or vomiting, feeling cold (especially in your arms and legs), feeling dizzy or lightheaded, and/or a fast or irregular heartbeat.
  • Serious liver problems. The liver may become large (hepatomegaly) and fatty (steatosis). Symptoms of liver problems include your skin or the white part of your eyes turns yellow (jaundice), dark “tea-colored” urine, light-colored bowel movements (stools), loss of appetite for several days or longer, nausea, and/or stomach pain.
  • You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight (obese), or have been taking STRIBILD for a long time. In some cases, these serious conditions have led to death. Call your healthcare provider right away if you have any symptoms of these conditions.
  • Worsening of hepatitis B (HBV) infection. If you also have HBV and stop taking STRIBILD, your hepatitis may suddenly get worse. Do not stop taking STRIBILD without first talking to your healthcare provider, as they will need to monitor your health. STRIBILD is not approved for the treatment of HBV.

What is STRIBILD?

STRIBILD® is a prescription medicine used to treat HIV-1 in people 12 years and older and weigh at least 77 pounds. It can either be used in people who are starting HIV-1 treatment and have never taken HIV-1 medicines before, or people who are replacing their current HIV-1 medicines and whose healthcare provider determines that they meet certain requirements. These include having an undetectable viral load (less than 50 copies/mL of virus in their blood) for 6 months or more on their current HIV-1 treatment. STRIBILD combines 4 medicines into 1 pill to be taken once a day with food. STRIBILD is a complete single tablet regimen and should not be used with other HIV-1 medicines.

STRIBILD does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking STRIBILD. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

The information in this section is intended for residents of the United States who are 18 years of age or older.

By following this link, you are now leaving
www.STRIBILD.com. This site is not controlled
by Gilead Sciences, Inc. Gilead Sciences, Inc. is not
responsible for the site's content or your use of it.

GET UPDATES

Sign up to receive updates when new information on STRIBILD is made available.


Submit

Terms and conditions

Gilead respects the privacy of your personal information. Gilead, and companies providing services to Gilead, may use the information that you provide to send you marketing or informational materials, analyze and use your information to improve or develop services and programs, and contact you about marketing programs or research and health topics that may be of interest to you.

Gilead, and companies providing services to Gilead, will not sell or rent your personally identifiable information. For more information regarding our Privacy Policy, click here.
Print

Thank you.

You will be notified as new information is made available on this Web site.